THPTA ligand
| Cat. # | Quantity | Price | Lead time | Buy this product |
|---|---|---|---|---|
| F4050 | 100 mg | $65 | in stock | |
| H4050 | 500 mg | $199 | in stock | |
| I4050 | 1 g | $369 | in stock | |
| K4050 | 5 g |
$1568
|
in stock |
THPTA ligand (tris-hydroxypropyltriazolylmethylamine) is a triazole ligand for water-based copper-catalyzed click chemistry reactions. This reagent is very well water-soluble. It is especially useful for click chemistry labeling and conjugation of proteins, including antibodies, when organic co-solvents are undesirable.
Customers also purchased with this product
DusQ 2 dT phosphoramidite
A phosphoramidite used for DusQ 2 dT labelling of oligonucleotides.
Add this product to your cart andget free express delivery
5-Ethynyl-uridine (EU)
Uridine alkyne derivative for monitoring and investigation of RNA transcription in cells.
Add this product to your cart andget free express delivery
AF 647 azide
Bright and photostable azide AF 647 for labeling alkyne-containing biomolecules and fluorescent visualization of biological objects.General properties
| Appearance: | off white solid |
| Molecular weight: | 434.5 |
| CAS number: | 760952-88-3 |
| Molecular formula: | C18H30N10O3 |
| IUPAC name: | 3-[4-[[bis[[1-(3-hydroxypropyl)triazol-4-yl]methyl]amino]methyl]triazol-1-yl]propan-1-ol |
| Solubility: | good in water, DMF, DMSO |
| Quality control: | NMR 1H, HPLC-MS (95%) |
| Storage conditions: | Storage: 24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. |
| MSDS: | Download |
| Product specifications |
Product citations
- Cardenas, A.J.; Thomas, K.S.; Broden, M.W.; Ferraro, N.J.; John, C.M.; Pires, M.M.; Jarvis, G.A.; Criss, A.K. Neisseria gonorrhoeaescavenges host sialic acid for Siglec-mediated, complement-independent suppression of neutrophil activation. bioRxiv, 2024, preprint. doi: 10.1101/2024.01.17.576097
- Slapak, E.J.; el Mandili, M.; Ten Brink, M.S.; Kros, A.; Bijlsma, M.F.; Spek, C.A. CAPN2-responsive mesoporous silica nanoparticles: A promising nanocarrier for targeted therapy of pancreatic cancer. Cancer Letters, 2024, 590, 216845. doi: 10.1016/j.canlet.2024.216845
- Narum, S.; Deal, B.; Ogasawara, H.; Mancuso, J. N.; Zhang, J.; Salaita, K. An Endosomal Escape Trojan Horse Platform to Improve Cytosolic Delivery of Nucleic Acids. ACS Nano, 2024, 18(8), 6186–6201. doi: 10.1021/acsnano.3c09027
- Slapak, E.J.; el Mandili, M.; Brink, M.S.T.; Kros, A.; Bijlsma, M.F.; Spek, C.A. Preclinical Assessment of ADAM9-Responsive Mesoporous Silica Nanoparticles for the Treatment of Pancreatic Cancer. International Journal of Molecular Sciences, 2023, 24(13), 10704. doi: 10.3390/ijms241310704
The count of items is incorrect.
Your cart is empty
$ 
